Tag Archives: Drug

Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio

Last October, England’s drug-cost watchdogs dealt Eli Lilly a blow when they decreed that the company’s CDK 4/6 inhibitor to treat breast cancer, Verzenio, wasn’t cost-effective. So Lilly dished up a new price break—and now the National Institute for Health and Care Excellence (NICE) is on board. The problem, initially, was that Lilly couldn’t provide evidence that Verzenio… Read More »

Viewpoints: The FDA Isn’t Up To The Task Of Reining In The Opioid Epidemic; The Downside Of Taking Children From Parents In Drug Treatment

Editorial writers weigh in on these and other health care topics. The Washington Post: This Is Why The Federal Government Has A Hard Time Regulating Prescription Opioids This past week, President Trump argued on national television that to end the opioid epidemic, Congress needed to fund the building of a wall at the United States’… Read More »

Indonesia seeks to reassure HIV patients over drug supplies

JAKARTA (Reuters) – Indonesia’s health ministry has sought to reassure HIV patients that sufficient antiretroviral (ARV) drugs will be available for their treatment after some hospitals had run out of supplies. At least 29 hospitals and health centres in Indonesia had exhausted their stocks of a particular type of ARV, known as a fixed-dose combination… Read More »